UPCOMING SESSIONS in ET
Thu, Jun 4, 2026
5:00 – 6:00 AM Bangkok
Cardiac Amyloidosis: New Strategies for Disease-Modifying Therapies Nitasha Sarswat Click To Register
UPCOMING SESSIONS in ET
Thu, Jun 4, 2026 · 5:00 – 6:00 AM Bangkok
Cardiac Amyloidosis: New Strategies for Disease-Modifying Therapies
Nitasha Sarswat
Click To Register
View all sessions

Symptoms of Heart Failure Should Prompt Suspicion of ATTR-CM

Source
Rare Disease Advisor

There are substantial delays from the time of incident heart failure to a diagnosis of transthyretin-mediated amyloid cardiomyopathy (ATTR-CM), according to a new study published in JAMA Cardiology.

Several factors associated with cardiomyopathy and breathlessness are also associated with a delayed ATTR-CM diagnosis, including female sex, a history of aortic stenosis, coronary artery disease, diabetes, high blood pressure, and chronic obstructive pulmonary disease (COPD).

“These findings highlight the need for a heightened index of suspicion for ATTR-CM in patients with other possible etiologies of cardiomyopathy or [heart failure] symptoms,” the authors of the study said.